These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 30348653)

  • 21. A conditioning platform based on fludarabine, busulfan, and 2 days of rabbit antithymocyte globulin results in promising results in patients undergoing allogeneic transplantation from both matched and mismatched unrelated donor.
    Devillier R; Fürst S; Crocchiolo R; El-Cheikh J; Castagna L; Harbi S; Granata A; D'Incan E; Coso D; Chabannon C; Picard C; Etienne A; Calmels B; Schiano JM; Lemarie C; Stoppa AM; Bouabdallah R; Vey N; Blaise D
    Am J Hematol; 2014 Jan; 89(1):83-7. PubMed ID: 24108528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cord Haploidentical Non-In Vitro T Cell Depletion Allogeneic Hematopoietic Stem Cell Transplantation Reduces Relapse of Refractory Acute Leukemia.
    Wang J; Wang Z; Wei W; Zhang W; Zhang T; Cheng H; Fei X; Yin Y; Gu J; Yuan L
    Biol Blood Marrow Transplant; 2019 Jan; 25(1):121-128. PubMed ID: 30205230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unrelated donor α/β T cell- and B cell-depleted HSCT for the treatment of pediatric acute leukemia.
    Leahy AB; Li Y; Talano JA; Elgarten CW; Seif AE; Wang Y; Johnson B; Monos DS; Kadauke S; Olson TS; Freedman J; Wray L; Grupp SA; Bunin N
    Blood Adv; 2022 Feb; 6(4):1175-1185. PubMed ID: 34872106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Haploidentical Transplantation with Post-Transplant Cyclophosphamide versus Unrelated Donor Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.
    Arcuri LJ; Aguiar MTM; Ribeiro AAF; Pacheco AGF
    Biol Blood Marrow Transplant; 2019 Dec; 25(12):2422-2430. PubMed ID: 31386903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Haploidentical HSCT with post transplantation cyclophosphamide versus unrelated donor HSCT in pediatric patients affected by acute leukemia.
    Saglio F; Berger M; Spadea M; Pessolano R; Carraro F; Barone M; Quarello P; Vassallo E; Fagioli F
    Bone Marrow Transplant; 2021 Mar; 56(3):586-595. PubMed ID: 32968215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alternative donor hematopoietic stem cell transplantation for sickle cell disease in Europe.
    Gluckman E; Cappelli B; Scigliuolo GM; De la Fuente J; Corbacioglu S
    Hematol Oncol Stem Cell Ther; 2020 Dec; 13(4):181-188. PubMed ID: 32201153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TcRαβ-depleted haploidentical transplantation results in adult acute leukemia patients.
    Kaynar L; Demir K; Turak EE; Öztürk ÇP; Zararsız G; Gönen ZB; Gökahmetoğlu S; Şıvgın S; Eser B; Köker Y; Solmaz M; Ünal A; Çetin M
    Hematology; 2017 Apr; 22(3):136-144. PubMed ID: 27724812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Bortezomib-Based Regimen Offers Promising Survival and Graft-versus-Host Disease Prophylaxis in Myeloablative HLA-Mismatched and Unrelated Donor Transplantation: A Phase II Trial.
    Koreth J; Kim HT; Lange PB; Bindra B; Reynolds CG; Chammas MJ; Armand P; Cutler CS; Ho VT; Glotzbecker B; Nikiforow S; Ritz J; Blazar BR; Soiffer RJ; Antin JH; Alyea EP
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):1907-13. PubMed ID: 26055298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unmanipulated haploidentical transplants compared with other alternative donors and matched sibling grafts.
    Raiola AM; Dominietto A; di Grazia C; Lamparelli T; Gualandi F; Ibatici A; Bregante S; Van Lint MT; Varaldo R; Ghiso A; Gobbi M; Carella AM; Signori A; Galaverna F; Bacigalupo A
    Biol Blood Marrow Transplant; 2014 Oct; 20(10):1573-9. PubMed ID: 24910379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HLA-haploidentical stem cell transplantation after removal of αβ+ T and B cells in children with nonmalignant disorders.
    Bertaina A; Merli P; Rutella S; Pagliara D; Bernardo ME; Masetti R; Pende D; Falco M; Handgretinger R; Moretta F; Lucarelli B; Brescia LP; Li Pira G; Testi M; Cancrini C; Kabbara N; Carsetti R; Finocchi A; Moretta A; Moretta L; Locatelli F
    Blood; 2014 Jul; 124(5):822-6. PubMed ID: 24869942
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T-cell-depleted haploidentical stem cell transplantation results improve with time in adults with acute leukemia: A study from the Acute Leukemia Working Party of the European Society of Blood and Marrow Transplantation (EBMT).
    Sestili S; Labopin M; Ruggeri A; Velardi A; Ciceri F; Maertens J; Kanz L; Aversa F; Lewalle P; Bunjes D; Mohty M; Nagler A
    Cancer; 2018 May; 124(10):2142-2150. PubMed ID: 29469924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of in vivo T cell depletion in HLA-identical allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission conditioned with a fludarabine iv-busulfan myeloablative regimen: a report from the EBMT Acute Leukemia Working Party.
    Rubio MT; D'Aveni-Piney M; Labopin M; Hamladji RM; Sanz MA; Blaise D; Ozdogu H; Daguindeau E; Richard C; Santarone S; Irrera G; Yakoub-Agha I; Yeshurun M; Diez-Martin JL; Mohty M; Savani BN; Nagler A
    J Hematol Oncol; 2017 Jan; 10(1):31. PubMed ID: 28118857
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Co-transplantation of mesenchymal stromal cell and haploidentical hematopoietic stem cell with TCR αβ depletion in children with primary immunodeficiency syndromes.
    Atay D; Akcay A; Akinci B; Yenigurbuz FD; Ovali E; Ozturk G
    Pediatr Transplant; 2021 Dec; 25(8):e14120. PubMed ID: 34409718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Matched versus Haploidentical Hematopoietic Stem Cell Transplantation as Treatment Options for Primary Immunodeficiencies in Children.
    Holzer U; Döring M; Eichholz T; Ebinger M; Queudeville M; Turkiewicz D; Schwarz K; Handgretinger R; Lang P; Toporski J
    Transplant Cell Ther; 2021 Jan; 27(1):71.e1-71.e12. PubMed ID: 32966882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transplantation in Children and Adolescents with Acute Lymphoblastic Leukemia from a Matched Donor versus an HLA-Identical Sibling: Is the Outcome Comparable? Results from the International BFM ALL SCT 2007 Study.
    Balduzzi A; Dalle JH; Wachowiak J; Yaniv I; Yesilipek A; Sedlacek P; Bierings M; Ifversen M; Sufliarska S; Kalwak K; Lankester A; Toporski J; Di Maio L; Glogova E; Poetschger U; Peters C
    Biol Blood Marrow Transplant; 2019 Nov; 25(11):2197-2210. PubMed ID: 31319153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impacts of thymoglobulin in patients with acute leukemia in remission undergoing allogeneic HSCT from different donors.
    Wakamatsu M; Terakura S; Ohashi K; Fukuda T; Ozawa Y; Kanamori H; Sawa M; Uchida N; Ota S; Matsushita A; Kanda Y; Nakamae H; Ichinohe T; Kato K; Murata M; Atsuta Y; Teshima T;
    Blood Adv; 2019 Jan; 3(2):105-115. PubMed ID: 30626574
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differences in Graft-versus-Host Disease Characteristics between Haploidentical Transplantation Using Post-Transplantation Cyclophosphamide and Matched Unrelated Donor Transplantation Using Calcineurin Inhibitors.
    Solh MM; Baron J; Zhang X; Bashey A; Morris LE; Holland HK; Solomon SR
    Biol Blood Marrow Transplant; 2020 Nov; 26(11):2082-2088. PubMed ID: 32745575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes of hematopoietic stem cell transplantation in 813 pediatric patients with Fanconi anemia.
    Lum SH; Eikema DJ; Piepenbroek B; Wynn RF; Samarasinghe S; Dalissier A; Kalwak K; Ayas M; Hamladji RM; Yesilipek A; Dalle JH; Uckan-Cetinkaya D; Bierings M; Kupesiz A; Halahleh K; Skorobogatova E; Öztürk G; Faraci M; Renard C; Evans P; Corbacioglu S; Locatelli F; Dufour C; Risitano A; Peffault de Latour R
    Blood; 2024 Sep; 144(12):1329-1342. PubMed ID: 38968140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bortezomib-based graft-versus-host disease prophylaxis in HLA-mismatched unrelated donor transplantation.
    Koreth J; Stevenson KE; Kim HT; McDonough SM; Bindra B; Armand P; Ho VT; Cutler C; Blazar BR; Antin JH; Soiffer RJ; Ritz J; Alyea EP
    J Clin Oncol; 2012 Sep; 30(26):3202-8. PubMed ID: 22869883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Who Is a Better Donor for Recipients of Allogeneic Hematopoietic Cell Transplantation: A Young HLA-Mismatched Haploidentical Relative or an Older Fully HLA-Matched Sibling or Unrelated Donor?
    Karam E; Laporte J; Solomon SR; Morris LE; Zhang X; Holland HK; Bashey A; Solh MM
    Biol Blood Marrow Transplant; 2019 Oct; 25(10):2054-2060. PubMed ID: 31173900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.